Top Restaurateur Tim Love on the Shake Shack IPO» Read More
The FMHR traders share their strategies to trading the global economy.
Stocks are selling off today but the Halftime traders still have some hot trades.
Boxing legend Sugar Ray Leonard, discusses his partnership with NBC Sports to bring fights to non-premium television.
The "Fast Money" traders debate whether now is the time to sell the banks or not.
Bill Nygren, Oakmark Funds, says now is the time to buy energy stocks, and reveals what two new stocks he is adding to his portfolio.
With stocks selling off sharply, CNBC's Steve Liesman and the "Fast Money" traders discuss market volatility and market trends.
CNBC's Dominic Chu reports Chipotle is suspending pork sales at a third of its restaurants. The "Fast Money" crew discusses the impact to its stock price.
Stifel analyst Scott Devitt, explains his upgrade of Netflix citing signals of strong international growth.
a volatile market has going down, up, down again ... and may be sideways for a little while. What should investors do?
The FMHR traders take their positions on four stocks making news today, including upgrades to Amazon and Best Buy.
Valeant CEO Mike Pearson tells CNBC's Meg Tirrell the company is on a mission to prove allegations against the business model are not true. Pearson says Valeant is unlikely to work with Bill Ackman.
Stephen Sather, El Pollo Loco CEO and president, discusses how lower oil prices are positive for the company's high-end fast casual structure. Sather also provides perspective into El Pollo Loco's trend towards healthier products.
Discussing how low earnings expectations will impact the broader market, with the FMHR traders.
Sam Isaly, OrbiMed Advisors, expects the health care sector to continue its strong performance in 2015. Isaly says there will be many takeovers in the space.
FMHR trader Jim Lebenthal shares his 2015 trading strategy, saying he's prepped for more volatility.
FMHR stock referee Mike Santoli provides perspective on the traders' portfolios in the battle for the trader of the year.
Brent Saunders, Actavis CEO, discusses the deal environment, the process of acquiring Allergan and the good that comes from activist investors.
Jeff Currie, Goldman Sachs head of commodities research, discusses his decision to cut his forecast for crude.
Anne Wojcicki, co-founder and CEO of genetic-testing startup 23andMe, discusses the new deals with Pfizer and Genentech.
One trader's thinks his key to success is minimizing losses with optimum timing of these trades.